Regenerative medicine

06Injury Healing and Regeneration — Index

From symptom management to genuine tissue repair: regenerative medicine aims to rebuild what's damaged rather than merely suppress symptoms. This section covers the full spectrum from conventional interventions (PRP, prolotherapy) to emerging approaches (peptides, electromagnetic therapies, frequency-specific microcurrent) that stimulate the body's innate healing capacity.

Why Regenerative Medicine Matters

Traditional medicine manages symptoms; regenerative medicine aims to:

• Rebuild tissue — Actual structural repair, not just pain relief
• Address root cause — Regeneration rather than suppression
• Reduce surgical interventions — Many surgeries can be avoided with proper regenerative care
• Enhance recovery — Speed and quality of healing beyond natural limits

The Paradigm Shift

Swipe table →

What Can Be Regenerated?

Not all tissues have equal regenerative capacity:

Swipe table →

Foundational

Swipe table →

Biological Injections

Swipe table →

Electromagnetic and Physical Modalities

Swipe table →

1. Prolotherapy

What it is: Injection of a proliferant solution (typically 15-25% dextrose) at ligament/tendon insertions to stimulate local healing and tissue strengthening.

Mechanism: 1. Local inflammation is triggered by the dextrose solution 2. Growth factors (PDGF, TGF-β, EGF) are released at the injury site 3. Fibroblast proliferation and collagen deposition occur 4. Over multiple sessions, tissue strength increases

Clinical applications: - Ligamentous laxity (knee, shoulder, ankle, spine) - Tendinopathy (tennis elbow, Achilles, rotator cuff) - Osteoarthritis (joint instability contributes to OA pain) - Myofascial pain (trigger point injection)

Evidence: Moderate; better for ligamentous instability than tendinopathy. Systematic reviews show reasonable evidence for chronic musculoskeletal pain (PMID 28854002).

Protocol: Typically 3-6 sessions spaced 2-4 weeks apart. Results build cumulatively.

Key distinction from PRP: Prolotherapy uses chemical irritation to stimulate healing; PRP delivers growth factors directly. Prolotherapy is cheaper and simpler; PRP requires blood draw and centrifugation.

2. PRP (Platelet-Rich Plasma)

What it is: Concentrated platelets from the patient's own blood, centrifuged to 3-8x baseline concentration, injected at the injury site.

Mechanism: Platelets contain over 300 bioactive proteins including: - PDGF (platelet-derived growth factor) — cell proliferation, angiogenesis - TGF-β (transforming growth factor beta) — collagen synthesis - VEGF (vascular endothelial growth factor) — blood vessel formation - EGF (epidermal growth factor) — tissue repair

Evidence by condition: | Condition | PRP Evidence | Notes | |-----------|-------------|-------| | Lateral epicondylitis | Strong (multiple RCTs) | Often superior to corticosteroids | | Patellar tendinopathy | Moderate-Strong | Multiple positive RCTs | | Achilles tendinopathy | Moderate | Less consistent than tennis elbow | | Knee osteoarthritis | Moderate | Better in early/moderate OA | | Hair loss | Moderate-Strong | Scalp injections for androgenic alopecia | | Plantar fasciitis | Moderate | Better when combined with exercise |

Critical factors affecting outcomes: - Leukocyte content: L-PRP (leukocyte-rich) vs. P-PRP (pure) — inflammatory vs. healing-optimized - Platelet concentration: 3-5x baseline is typical; higher is not clearly better - Activation: Thrombin, calcium chloride, or endogenous activation — affects release kinetics - Injection volume and technique: Exact placement matters

3. Stem Cell Therapies

What it is: Mesenchymal stem cells (MSCs) — typically from bone marrow aspirate (BMAC), adipose tissue, or birth tissue (Wharton's jelly, amniotic fluid) — injected to promote tissue repair.

Mechanism: - Multi-potent differentiation (bone, cartilage, tendon, muscle) - Immunomodulation (anti-inflammatory, anti-scarring) - Paracrine signaling (growth factors, cytokines) - Homing to injury sites

Key distinctions by source: | Source | MSC Count | Evidence Quality | Regulatory Status | |--------|-----------|-----------------|-------------------| | Bone marrow (BMAC) | Low; requires concentration | Best-studied | FDA-compliant | | Adipose tissue | Higher yield | Moderate | Variable | | Birth tissue (amniotic) | High marketing claims | Weak; often no viable cells | Often unproven | | Umbilical cord (Wharton's jelly) | High | Growing | Variable |

Evidence: Early. The mechanism is strong; clinical outcomes are variable and depend heavily on processing quality, cell viability, and injection technique.

Important warning: Many "stem cell" clinics use birth tissue products that have no viable stem cells or only dead/cryopreserved cells. The FDA has issued warnings about these clinics. Bone marrow-derived (BMAC) is the most evidence-backed.

4. Peptide Therapy for Injury

The most evidence-supported peptides for tissue repair:

Swipe table →

See Peptide Therapy for Injuries for detailed protocols and evidence evaluation.

Critical caveat: BPC-157 and TB-500 are not FDA-approved for any condition. Most evidence is preclinical (animal studies). Use at patient's own risk, typically via research peptide suppliers with third-party testing.

5. Electromagnetic Therapies

PEMF (Pulsed Electromagnetic Field)

Mechanism: Low-intensity electromagnetic fields (typically 15-30 Hz, 0.1-10 mT) affect cellular membrane potentials, calcium channel activity, and signaling pathways.

Evidence by application: | Application | Evidence | Notes | |-------------|---------|-------| | Fracture healing (non-unions) | Strong | FDA-approved for fracture healing | | Osteoarthritis (knee) | Moderate | Pain and function improvement | | Tendinopathy | Moderate | Anti-inflammatory effect | | Soft tissue healing | Moderate | Wounds, edema | | Depression/anxiety | Low-moderate | Cranial PEMF devices (Fisher Wallace, etc.) |

Frequency-Specific Microcurrent (FSM)

Distinct from generic microcurrent, FSM uses paired frequencies applied via specific amplitude settings:

• Theory: Each tissue type (muscle, nerve, scar, inflammation) has a frequency that affects its conductance. Paired frequencies — a "carrier" frequency for the tissue and a "condition" frequency for the pathology — are applied simultaneously.
• Evidence: Moderate for wound healing and DOMS (delayed onset muscle soreness). The paired-frequency specificity theory is less well-supported; generic microcurrent has better evidence for tissue healing than FSM's specific claims.
• Key distinction: FSM ≠ generic microcurrent. Generic microcurrent has reasonable evidence for ATP increase and protein synthesis in wound healing; FSM adds theoretical frequency-pair specificity.

See Frequency-Specific Microcurrent for detailed protocols and the evidence evaluation.

Shockwave Therapy (Extracorporeal)

• Radial shockwave (pressure wave): Superficial; good for tendinopathy
• Focused shockwave (acoustic wave): Deeper; used for bone and deep tissue
• Mechanism: Mechanical microtrauma → neovascularization → growth factor release → tissue remodeling
• Evidence: Moderate to strong for tendinopathy (tennis elbow, plantar fasciitis, Achilles); moderate for bone healing

6. Hyperbaric Oxygen Therapy (HBOT)

What it is: Breathing 100% oxygen at 1.5-3.0 ATA in a pressurized chamber. This dissolves oxygen in plasma, creating 10-20x normal tissue oxygen levels.

Mechanism: - Hyperoxia → reactive oxygen species (ROS) and reactive nitrogen species (RNS) - At moderate pressures and intermittent exposure: adaptive, hormetic oxidative stress → antioxidant defense upregulation - Neovascularization (VEGF stimulation) - Reduced inflammation (NF-κB inhibition) - Stem cell mobilization

Evidence by application: | Application | Evidence | Notes | |-------------|---------|-------| | Diabetic foot wounds | Strong | Standard of care | | Radiation injury | Strong | Tissue salvage | | Post-concussion/brain injury | Moderate | Emerging evidence; controversial | | Normal wound healing | Moderate | Accelerates healing | | Anti-aging / performance | Low | Anecdotal; no RCTs |

See Hyperbaric Oxygen Therapy for detailed protocols.

By Condition Type

Swipe table →

By Evidence Preference

Swipe table →

Evidence Level by Modality

Swipe table →

Finding a Practitioner

• Regenerative medicine specialists — Often orthopedists, physiatrists, or sports medicine doctors with fellowship training
• Sports medicine — Many offer regenerative options
• Naturopathic doctors — Some offer prolotherapy, PRP (varies by state/country)
• Pain management physicians — Often have broadest range of regenerative options

Questions to Ask a Practitioner

1. What is the source and preparation method for your PRP/stem cells?
2. How many of these procedures have you performed for my specific condition?
3. What are your outcome success rates (objectively measured)?
4. What imaging or assessment do you do before and after?
5. Do you do ultrasound-guided injections? (精度 is critical for joint/tendon injections)
6. What is the expected timeline for improvement?
7. What are the realistic expectations vs. marketing claims?

Costs (US Ranges — Generally Not Covered by Insurance)

Swipe table →

What to Expect

• Multiple sessions typically needed for prolotherapy and PRP
• Results often take weeks to months to fully manifest
• Rehabilitation and progressive loading often part of the protocol
• Not all conditions respond — response rates vary by condition and individual
• Combination approaches often work better than single modalities
• Imaging (MRI/ultrasound) before and after provides objective assessment

Connection to Other Sections

• Overview - Therapeutic Peptides — Peptide protocols: BPC-157, TB-500, GHK-Cu
• Overview - Photobiomodulation — Red light therapy for tissue healing; PBM accelerates wound closure
• Overview - Longevity Science — Regenerative approaches overlap with longevity (stem cells, healing)
• Mitochondrial Health — Recovery depends on cellular energy; mitochondrial function underpins tissue repair
• Pain Management — DMSO and topical approaches for pain without systemic medication
• Frequency-Specific Microcurrent — Detailed FSM evidence and protocols

Notes

This section is strongest where there are objective structural endpoints: tendon imaging, wound area measurement, fracture union rates, range of motion, and validated functional scores.

Regenerative interventions work best when paired with: - Progressive mechanical loading — Tissue remodeling requires appropriate stress; biologics without rehabilitation is usually incomplete - Adequate nutrition — Protein, vitamin C, zinc, magnesium are co-factors for collagen synthesis - Sleep optimization — Growth hormone pulses during deep sleep drive tissue repair - Metabolic optimization — Insulin resistance impairs healing; blood sugar control matters

The most overhyped area is stem cells from birth tissue (amniotic, umbilical cord) — many clinics charge thousands for products containing no viable stem cells. Bone marrow-derived (BMAC) is the most evidence-backed stem cell source.

The most underutilized is prolotherapy — it's inexpensive, has a reasonable evidence base, and is widely available, but often overlooked in favor of more expensive options.

Future expansion priorities: shockwave therapy detailed protocols, tendinopathy-specific PRP evidence by tendon location, FSM frequency-pair tables with evidence ratings, and clearer separation of stem cell evidence by source and regulatory status.